Mitochondrial fragmentation is involved in methamphetamine-induced cell death in rat hippocampal neural progenitor

Changhai Tian1, L Charles Murrin, Jialin C Zheng

  • 1The Laboratory of Neurotoxicology at the Center for Neurovirology & Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Plos One
|May 14, 2009
PubMed

Insights

Methamphetamine (METH) causes neurodegeneration by damaging neural progenitor cells (NPCs). METH-induced reactive oxygen species (ROS) disrupt dynamin-related protein 1 (Drp1), leading to mitochondrial fragmentation and cell death.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Toxicology

Background:

  • Methamphetamine (METH) is known to cause neurodegeneration in dopaminergic neurons.
  • The impact of METH on neural progenitor cells (NPCs), crucial for neural repair, is not well understood.
  • Understanding METH's effects on NPCs is vital for addressing METH-related neurotoxicity.

Purpose of the Study:

  • To investigate the effects of METH on rat hippocampal NPCs (rhNPCs).
  • To elucidate the molecular mechanisms underlying METH-induced cell damage in rhNPCs.
  • To identify potential therapeutic targets for METH-induced neurodegeneration.

Main Methods:

  • Primary rat hippocampal NPC culture.
  • Immunocytochemistry, flow cytometry, and Western blotting to assess cell viability, apoptosis, and mitochondrial function.
  • Analysis of key proteins involved in mitochondrial dynamics and oxidative stress.

Main Results:

  • METH induced mitochondrial fragmentation, apoptosis, and inhibited proliferation in rhNPCs.
  • Reactive oxygen species (ROS) and dynamin-related protein 1 (Drp1) were identified as key mediators of METH-induced mitochondrial damage.
  • ROS dysregulation led to Drp1 oligomerization and translocation, causing mitochondrial fragmentation.

Conclusions:

  • METH-induced ROS generation triggers Drp1 dysregulation, leading to mitochondrial fragmentation and apoptosis in rhNPCs.
  • This study reveals a novel mechanism for METH neurotoxicity targeting neural progenitor cells.
  • Findings offer insights into potential therapeutic strategies for METH-induced neurodegenerative disorders.

Related Concept Videos